Singular Genomics Systems, Inc.: Nasdaq/NYSE listing notice — Singular Genomics receives Nasdaq deficiency notice for bid price below $1.00

Singular Genomics Systems, Inc.

Received deficiency letter on July 17, 2023, for failure to meet $1.00 minimum bid price for 30 consecutive days.
Has 180 calendar days, until January 15, 2024, to regain compliance by closing at $1.00 for 10 consecutive days.
May qualify for additional 180-day period if it transfers to Nasdaq Capital Market and meets requirements.
Stock continues trading under symbol OMIC; no immediate delisting effect.
Company intends to monitor and consider options; no assurance of regaining compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Singular Genomics Systems, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

July 17, 2023, Singular Genomics Systems, Inc. (the “Company”) received a deficiency letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days prior to the date of the Letter, the bid price for the Company’s common stock (the “Common Stock”) closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Letter is a notice of deficiency, and not delisting, and has no imm

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-23-033682

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.